News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Asthma patients to breathe easier

Media release

Asthma patients to breathe easier

New Zealanders will have easy access to an asthma medicine from 1 November.

Government drug-funder PHARMAC has announced a decision to widen access to salmeterol (Serevent) asthma inhalers, one of the group of treatments known as long-acting beta agonists (LABAs). These are used by people whose asthma is not adequately controlled using inhaled corticosteroids, such as beclomethasone (Beclazone), budesonide (Pulmicort) or fluticasone (Flixotide) alone.

From 1 November prescribing of salmeterol will be subject to a guideline, rather than the current need for Special Authority approval. This will make it easier for people to obtain salmeterol through their GP.

PHARMAC Medical Director Dr Peter Moodie says the decision will have a significant impact on people with asthma.

“We have seen evidence that greater asthma control is achieved by combining a LABA with inhaled steroid treatment, rather than increasing doses of inhaled steroids alone,” Dr Moodie says. “This decision will mean people will be able to add a LABA (salmeterol) to their treatment at a lower inhaled steroid dose.”

“We anticipate that widening access will result in an additional 15,000 people taking LABAs over the next three years.” Currently approximately 40,000 people are using LABAs.

Dr Moodie says the type of inhaler used for salmeterol, an aerosol, is the preferred type used by many New Zealanders. Currently, most people prescribed LABAs use a dry powder device. Dr Moodie says the type of inhaler will probably mean that most new patients prescribed a LABA will choose salmeterol.

The salmeterol access widening is anticipated to result in expenditure rising by about $8 million over the next five years.

The decision is the latest funding announcement by PHARMAC and follows decisions to widen access to the osteoporosis treatment alendronate, mycophenolate for transplants, diabetes medicine pioglitazone, and the aromatase inhibitors for breast cancer.


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


NZ On Air TV Funding: More Comedy Comes Out Of The Shadows

Paranormal Event Response Unit is a series conceived by Jemaine Clement and Taika Waititi as a TV spin-off from their highly acclaimed feature film What We Do In The Shadows. More>>


Mars News: Winners Announced For The 2016 Apra Silver Scroll Awards

Wellington singer-songwriter and internationally acclaimed musician Thomas Oliver has won the 2016 APRA Silver Scroll Award with his captivating love song ‘If I Move To Mars’. More>>


Scoop Review Of Books: Salt River Songs by Sam Hunt

Colin Hogg, a longtime comrade of Sam, writes in his Introduction that, ‘There is a lot of death in this collection of new poems by my friend Sam Hunt. It’s easier to count the poems here that don’t deal with the great destroyer than it is to point to the ones that do.’ More>>

Electronica: Restoring The World’s First Recorded Computer Music

University of Canterbury Distinguished Professor Jack Copeland and UC alumni and composer Jason Long have restored the earliest known recording of computer-generated music, created more than 65 years ago using programming techniques devised by Alan Turing. More>>


Scoop Review Of Books: Almost Getting Away With Murder

The Black Widow by Lee-Anne Cartier: Lee-Anne Cartier is the sister of the Christchurch man found to have been murdered by his wife, Helen Milner, after an initial assumption by police that his death, in 2009, was suicide. More>>

Howard Davis: Triple Echo - The Malevich/Reinhardt/Hotere Nexus

Howard Davis: The current juxtaposition of works by Ralph Hotere and Ad Reinhardt at Te Papa perfectly exemplifies Jean Michel Massing's preoccupation with the transmigration of imagery in a remarkable triple echo effect... More>>

Get More From Scoop



Search Scoop  
Powered by Vodafone
NZ independent news